Alar Pharmaceuticals Inc.
2 clinical trials · Sponsor
◉ Watch Alar Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Multiple Ascending Dose Phase 1 Study of ALA-3000 (NCT06965569) | Alar Pharmaceuticals Inc. | 2025-04-21 |
| Single Ascending Dose Study of ALA-1000 (NCT04122755) | Alar Pharmaceuticals Inc. | 2019-09-16 |
Track Alar Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.